A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

Clinical trial NCT03251118 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03251118
Sponsor: Target PharmaSolutions, Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Inflammatory Bowel Diseases Crohn's Disease Ulcerative Colitis Indeterminate Colitis

Start date: 2017-07-24
Primary completion: 2027-03-01
Enrollment: 15000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.